EUCTR2008-005819-18-SEActive, not recruitingNot Applicable
A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia. - DysBot
Department of Neuroscience, Uppsala University0 sitesStarted: February 27, 2009Last updated:
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Patients who are 18 years of age or older with diagnosed cervical dystonia that has been treated with Dysport regularly for at least one year prior to the study with stabilised treatment response.
- •Signed informed consent must be obtained before any study-related procedures are conducted.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Contraindications to any of the investigational products, pregnancy or lactation, multifocal or generalised dystonia, patients with deep brain stimulation (DBS) treatment, patients with ongoing pronounced variability in daily bensodiazepine dose, = 2 mg clonazepam or corresponding doses of other bensodiazepines, patients suffering from other conditions that, in the opinion of the investigator, might interfere with the study objectives or patients that, in the opinion of the investigator, are unable to comply with study requirements.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A Prospective Evaluation of BOTOX® and Dysport® in Temporal Brow Elevation - BOTOX® vs. Dysport® in Brow LiftFor subjects who desire brow lift as a means to rejuvenate the upper face.EUCTR2005-005252-40-BEAalst Dermatology Group40
Completed
Phase 4
Field of Effects of Two Commercial Preparations of Botulinum Toxin Type AWrinkles in Frontal AreaNCT00989768Brazilan Center for Studies in Dermatology29
Not yet recruiting
Phase 3
Evaluation of the effect of Botox in addition to Diltiazem ointment in chronic anal fissureIRCT20151020024625N13Semnan University of Medical Sciences64
Recruiting
Phase 4
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic ScoliosisAdolescent Idiopathic ScoliosisNCT03935295Johns Hopkins University90
Completed
Phase 1
Botulinum toxin-loaded detachable dissolvable microneedles for primary axillary hyperhidrosis: A pilot study on efficacy and safetyaxillary sweatingMicroneedle Transdermal Botulinum Toxin Botox Patch testTCTR20201230002Material and Bio interface10